Donghua Zhang
Clinical trials sponsored by Donghua Zhang, explained in plain language.
-
New CAR-T therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests a new treatment called BAFFR CAR-T for people with B-cell blood cancers that have returned or not responded to standard therapy. The therapy uses a patient's own immune cells, modified to attack cancer cells. The goal is to see if it is safe and helps control the…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can supercharged immune cells stop leukemia from returning?
Disease control Recruiting nowThis study tests whether infusing special immune cells called γδ T cells can prevent relapse in people with high-risk acute myeloid leukemia (AML) who have had a stem cell transplant. The trial will enroll 40 adults aged 18 to 65. The main goal is to see if the treatment improves…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC